Pulse.

a daily field guide to health research that matters

◆ Console

‹ Wed · 28 Oct 2026
Standard addition

Efficacy and safety of Lianhua Qingwen versus oseltamivir in children with influenza: a multicenter, randomized, double-blind, positive parallel-controlled study.

A traditional Chinese herbal remedy worked as well as oseltamivir for childhood flu, potentially offering families more treatment options.

This randomized controlled trial evaluated Efficacy and safety of Lianhua Qingwen versus oseltamivir in children with influenza: a multicenter, randomized, double-blind, positive parallel-controlled study. The abstract reports LHQW was non-inferior to oseltamivir in clinical recovery time and resulted in faster defervescence and greater improvement in cough and sore throat, with comparable safety.

What the study was

Study design
Randomized controlled trial
Population
Human participants or patients described in the PubMed abstract
Category
Other
Maturity
Validated
Journal
Pharm Biol

Why it surfaced

Randomized controlled trial; PubMed abstract reviewed; conservative score reflects design, direct relevance, and evidence maturity.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.